Clincosm LogoSign in Get a demo

stage iiib ovarian cancer

Showing 1 - 19 of 19
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia, Brain Glioblastoma, Estrogen Receptor Negative Trial in Fullerton (Best Practice, Laboratory Biomarker

Active, not recruiting
  • Acute Myeloid Leukemia
  • +66 more
  • Best Practice
  • +3 more
  • Fullerton, California
    Virginia K Crosson Cancer Center
Jan 31, 2022

Stage III Fallopian Tube Cancer, Stage III Ovarian Cancer, Stage III Primary Peritoneal Cancer Trial in Seattle (drug,

Terminated
Has Results
  • Stage III Fallopian Tube Cancer
  • +14 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Dec 17, 2021

Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma, Stage I Ovarian Cancer Trial in Buffalo (procedure, drug, other)

Completed
  • Fallopian Tube Carcinoma
  • +14 more
  • Diagnostic Microscopy
  • +2 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Oct 5, 2021

Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma

Completed
Has Results
  • Fallopian Tube Clear Cell Adenocarcinoma
  • +26 more
  • Bevacizumab
  • +5 more
  • Anniston, Alabama
  • +631 more
Jul 19, 2019

Advanced Malignant Tumor, Cervical Squamous Cell Carcinoma, Endometrial Carcinoma Trial in Scottsdale, Rochester (Laboratory

Completed
  • Advanced Malignant Neoplasm
  • +31 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Scottsdale, Arizona
  • +1 more
Jun 5, 2019

Adult Hepatocellular Carcinoma, Advanced Adult Hepatocellular Carcinoma, Endometrial Serous Adenocarcinoma Trial in Canada,

Completed
Has Results
  • Adult Hepatocellular Carcinoma
  • +44 more
  • Scottsdale, Arizona
  • +60 more
Jan 24, 2019

Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Cancer, Stage IIIA Primary Peritoneal Cancer Trial (drug, procedure, other)

Withdrawn
  • Stage IIIA Fallopian Tube Cancer
  • +11 more
  • (S)-4-(3-[18F]Fluoropropyl)-L-glutamic acid (18F-FSPG)
  • +2 more
  • (no location specified)
Jun 4, 2018

Nausea and Vomiting, Ovarian Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma Trial in Hinsdale, Providence (procedure,

Terminated
Has Results
  • Nausea and Vomiting
  • +26 more
  • Adjuvant Therapy
  • +7 more
  • Hinsdale, Illinois
  • +1 more
Apr 24, 2018

YKL-40 in Serum Samples From Newly Diagnosed Stage III-IV

Terminated
  • Fallopian Tube Adenocarcinoma
  • +29 more
  • Cytology Specimen Collection Procedure
  • Laboratory Biomarker Analysis
  • Mobile, Alabama
  • +130 more
May 21, 2018

Stage I Breast Cancer, Stage I Cervical Cancer, Stage I Ovarian Cancer Trial in Philadelphia, Reading (Informational

Completed
  • Stage I Breast Cancer
  • +38 more
  • Informational Intervention
  • Philadelphia, Pennsylvania
  • +1 more
Feb 20, 2018

Stage IA Fallopian Tube Cancer, Stage IA Ovarian Cancer, Stage IB Fallopian Tube Cancer Trial in United States (Laboratory

Completed
Has Results
  • Stage IA Fallopian Tube Cancer
  • +23 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Mobile, Alabama
  • +45 more
Sep 12, 2017

Tumor Tissue Samples From Undergone Surgery for Advanced Stage

Recruiting
  • Stage IIIA Ovarian Cancer
  • +3 more
  • Laboratory Biomarker Analysis
  • Philadelphia, Pennsylvania
    Gynecologic Oncology Group
May 2, 2017

Estrogen Receptor Negative, Head and Neck Squamous Cell Carcinoma, HER2/Neu Negative Trial (Laboratory Biomarker Analysis,

Withdrawn
  • Estrogen Receptor Negative
  • +22 more
  • Laboratory Biomarker Analysis
  • +2 more
  • (no location specified)
Apr 20, 2017

Caregiver, Stage IIIA Ovarian Cancer, Stage IIIB Ovarian Cancer Trial in Seattle (Telephone-Based Intervention,

Completed
  • Caregiver
  • +4 more
  • Telephone-Based Intervention
  • +3 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Mar 6, 2017

Chemotherapeutic Agent Toxicity, Neuropathy, Neurotoxicity Syndrome Trial in United States (Carboplatin, Glutathione, Laboratory

Completed
Has Results
  • Chemotherapeutic Agent Toxicity
  • +15 more
  • Mobile, Alabama
  • +389 more
Jan 5, 2017

Collecting Tumor Samples From Patients With Gynecological Tumors

Completed
  • Borderline Ovarian Clear Cell Tumor
  • +85 more
  • Laboratory Biomarker Analysis
  • Fayetteville, Arkansas
  • +186 more
Oct 26, 2016

Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma Trial in Buffalo (biological, other, drug)

Completed
  • Anaplastic Astrocytoma
  • +64 more
  • DEC-205/NY-ESO-1 Fusion Protein CDX-1401
  • +3 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Oct 3, 2016

Malignant Ovarian Clear Cell Tumor, Malignant Ovarian Serous Tumor, Recurrent Fallopian Tube Carcinoma Trial (Aldesleukin,

Withdrawn
  • Malignant Ovarian Clear Cell Tumor
  • +16 more
  • Aldesleukin
  • +3 more
  • (no location specified)
Feb 15, 2016

Patients With Advanced Ovarian Epithelial Cancer

Withdrawn
  • Ovarian Serous Cystadenocarcinoma
  • +5 more
  • Comparative Genomic Hybridization
  • +2 more
  • Philadelphia, Pennsylvania
    Gynecologic Oncology Group
May 29, 2015